The FDA has approved Benlysta for SC administration using an autoinjector in patients 5 years of age and older with active LN.

These are called autoantibodies. In a 2015 study in the journal Arthritis and Rheumatology, a group of Canadian researchers ...

Glaxosmithkline, with multiple operations in Montco, just scored a major regulatory win that could reshape how lupus ...

Autoimmune diseases like lupus rheumatoid arthritis and psoriasis don’t just affect joints or skin they can silently damage ...

The U.S. Food and Drug Administration has approved GSK's autoinjector of Benlysta (belimumab) for subcutaneous injection in ...

The FDA has approved Gamifant as the first-ever treatment for macrophage activation syndrome in Still’s disease for adults ...

Gamifant marks the first-ever FDA-approved treatment for both adult and pediatric patients with hemophagocytic ...

GSK plc (NYSE:GSK) is one of the 11 best European stocks to invest in. On June 24, the company announced receipt of FDA ...

48. van den Akker M, Silverman E, Abdelhaleem M, Kirby-Allen M. Aplastic anemia associated with systemic lupus erythematosus in children - case report and review of the literature.

Objectives To investigate dry eye disease (DED) in patients affected by systemic lupus erythematosus (SLE). Methods We conducted a systematic search of the literature on PubMed, EMBASE and the ...

Belimumab autoinjector is now approved and available for pediatric patients with lupus nephritis. The US Food and Drug Administration (FDA) has approved the belimumab 200 mg/mL autoinjector for ...

About systemic lupus erythematosus (SLE) and lupus nephritis (LN) Systemic lupus erythematosus (SLE), the most common form of lupus, is a chronic, incurable, autoimmune disease associated with a range ...